61
Obscure GI Bleeding Obscure GI Bleeding Kathy Bull-Henry, MD Kathy Bull-Henry, MD Georgetown University Hospital Georgetown University Hospital Division of Gastroenterology Division of Gastroenterology

ObscureGIBleeding

Embed Size (px)

Citation preview

Page 1: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 1/61

Obscure GI BleedingObscure GI BleedingKathy Bull-Henry, MDKathy Bull-Henry, MD

Georgetown University HospitalGeorgetown University HospitalDivision of GastroenterologyDivision of Gastroenterology

Page 2: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 2/61

GI BleedingGI BleedingDefinitionsDefinitions

Page 3: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 3/61

Obscure GI BleedingObscure GI BleedingDefinitionDefinition

Bleeding of unknown originBleeding of unknown origin that persists or that persists or 

recurs after negative colonoscopy andrecurs after negative colonoscopy and

negative upper endoscopynegative upper endoscopy

Recurrent or persistent bleedingRecurrent or persistent bleeding FOBT positiveFOBT positive

IDAIDA

Visible bleedingVisible bleeding

Melena, hematemesis, hematochezia, coffeeMelena, hematemesis, hematochezia, coffee

groundsgrounds

Page 4: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 4/61

Obscure-Occult GI BleedingObscure-Occult GI BleedingFrequencyFrequency

Page 5: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 5/61

Obscure GI BleedingObscure GI BleedingFrequencyFrequency

10% - 20% of GI bleeding without10% - 20% of GI bleeding without

identifiable etiologyidentifiable etiology

5% GI bleeding recurrent without5% GI bleeding recurrent without

identifiable etiologyidentifiable etiology Majority have small bowel sourceMajority have small bowel source

Page 6: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 6/61

Obscure GI BleedingObscure GI Bleeding

Small BowelSmall Bowel CausesCauses

Grouped by AgeGrouped by Age

Patient’s < 25 years oldPatient’s < 25 years old

Meckel’s DiverticulaMeckel’s DiverticulaPatient’s between 30 – 50 years oldPatient’s between 30 – 50 years old TumorsTumors

Patient’s > 50 years oldPatient’s > 50 years old Vascular ectasiasVascular ectasias

Page 7: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 7/61

Small Bowel BleedingSmall Bowel Bleeding

 CausesCauses

By EtiologyBy Etiology

Vascular LesionsVascular Lesions

NeoplasmsNeoplasmsInflammatory LesionsInflammatory Lesions

Other Other 

Page 8: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 8/61

Small Bowel BleedingSmall Bowel BleedingVascular LesionsVascular Lesions

Most common cause of small bowelMost common cause of small bowel

bleedingbleeding

Responsible for 70 -80% of small bowelResponsible for 70 -80% of small bowel

bleedingbleeding

Page 9: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 9/61

Small Bowel BleedingSmall Bowel BleedingVascular LesionsVascular Lesions

 Angioectasias Angioectasias

TelangiectasiasTelangiectasias Hereditary hemorrhagic telangiectasiaHereditary hemorrhagic telangiectasia Osler-Weber-Rendu SyndromeOsler-Weber-Rendu Syndrome

CREST SyndromeCREST Syndrome CCalcinosis,alcinosis, RReynaud’s,eynaud’s, EEsophageal dysmotilitysophageal dysmotility SSclerodactyl,clerodactyl,

TTelangiectasiaelangiectasia

Other Other  Dieulafoy’s lesionDieulafoy’s lesion  Aortoenteric fistula Aortoenteric fistula Small bowel varicesSmall bowel varices

Page 10: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 10/61

Small Bowel BleedingSmall Bowel Bleeding Angiodysplasia Angiodysplasia

Dilated tortuous blood vessels with thinDilated tortuous blood vessels with thin

walls lined by endothelium with little or nowalls lined by endothelium with little or no

smooth musclesmooth muscle

Most common small bowel bleeding in theMost common small bowel bleeding in the

elderly (> 50 years old)elderly (> 50 years old)

May be associated with aging associatedMay be associated with aging associated

degeneration of vascular integritydegeneration of vascular integrity

Page 11: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 11/61

Small Bowel BleedingSmall Bowel Bleeding

TumorsTumors

Second most common cause of bleedingSecond most common cause of bleeding

One out of ten patients with obscure bleeding will have aOne out of ten patients with obscure bleeding will have asmall bowel tumor small bowel tumor 

Most common cause in persons age 30 – 50 years of ageMost common cause in persons age 30 – 50 years of age

Malignant and BenignMalignant and Benign  Adenocarcinoma, carcinoid, lymphoma, leiomyosarcoma, Adenocarcinoma, carcinoid, lymphoma, leiomyosarcoma, Leiomyoma, polyps (Peutz-Jeghers, familial polyposis), GISTLeiomyoma, polyps (Peutz-Jeghers, familial polyposis), GIST

MetastaticMetastatic Melanoma, breast, renal-cell, kaposi’s sarcoma, colon, ovarianMelanoma, breast, renal-cell, kaposi’s sarcoma, colon, ovarian

Page 12: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 12/61

Causes of Small Bowel BleedingCauses of Small Bowel Bleeding

DiverticulaDiverticula

Small bowel diverticulaSmall bowel diverticula  At the site of perforating blood vessels At the site of perforating blood vessels

Meckel’s diverticulumMeckel’s diverticulum Remnant of vitelline duct in distal ileumRemnant of vitelline duct in distal ileum Most common cause of small bowel bleeding inMost common cause of small bowel bleeding in

patients under the age of 25 years oldpatients under the age of 25 years old

Ectopic gastric tissue causes ulcerationEctopic gastric tissue causes ulceration IntussusceptionIntussusception Inverted Meckel’s, angioectasias, submucosal tumorsInverted Meckel’s, angioectasias, submucosal tumors

Page 13: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 13/61

Small Bowel BleedingSmall Bowel BleedingInflammatory LesionsInflammatory Lesions

Crohn’s DiseaseCrohn’s Disease

Isolated ulcersIsolated ulcers

Idiopathic ulcersIdiopathic ulcers Nonsteroidal antiinflammatory drugsNonsteroidal antiinflammatory drugs

IschemicIschemic

Other Other  Vasculitis, Zollinger-Ellison syndrome, CeliacVasculitis, Zollinger-Ellison syndrome, Celiac

diseasedisease

Page 14: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 14/61

Small Bowel BleedingSmall Bowel BleedingRare CausesRare Causes

HemobiliaHemobilia Neoplasm, vascular aneurysm, liver abscess, trauma,Neoplasm, vascular aneurysm, liver abscess, trauma,

liver biopsyliver biopsy

Hemosuccus pancreaticusHemosuccus pancreaticus Pancreatic pseudocysts, pancreatitis, neoplasmsPancreatic pseudocysts, pancreatitis, neoplasms

Erosion into a vessel with communication with PDErosion into a vessel with communication with PD

InfectionsInfections Cytomegalovirus, histoplasmosis, TbCytomegalovirus, histoplasmosis, Tb

Page 15: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 15/61

Obscure GI BleedingObscure GI BleedingSummary CausesSummary Causes

Page 16: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 16/61

Obscure GI BleedingObscure GI BleedingSmall Bowel VisualizationSmall Bowel Visualization

 

Difficult to visualizeDifficult to visualize

Length (6.7 m)Length (6.7 m)Free intraperitoneal locationFree intraperitoneal location

Vigorous contractilityVigorous contractility

Overlying loopsOverlying loops

Page 17: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 17/61

Small Bowel BleedingSmall Bowel Bleeding

DiagnosisDiagnosis

UGI SBFTUGI SBFT EnteroclysisEnteroclysis

Push enteroscopyPush enteroscopy Double balloon enteroscopyDouble balloon enteroscopy Intraoperative enteroscopyIntraoperative enteroscopy

CT scanCT scan CT enteroclysisCT enteroclysis

MRIMRI

Video capsule endoscopyVideo capsule endoscopy

Page 18: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 18/61

Obscure BleedingObscure BleedingSBFT and EnteroclysisSBFT and Enteroclysis

SBFTSBFT 0-5.6% diagnostic yield0-5.6% diagnostic yield

EnteroclysisEnteroclysis Superior to SBFTSuperior to SBFT Double contrast, Tube into proximal small bowelDouble contrast, Tube into proximal small bowel

Inject barium, methylcellulose, air Inject barium, methylcellulose, air 

Performed with CT and MRIPerformed with CT and MRI

Only 10-21% diagnostic yieldOnly 10-21% diagnostic yield

Use if capsule endoscopy or enteroscopy unavailableUse if capsule endoscopy or enteroscopy unavailable

Page 19: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 19/61

Obscure GI BleedingObscure GI BleedingNuclear ScansNuclear Scans

Technetium (99mTc) sulfur colloidTechnetium (99mTc) sulfur colloid

Technetium 99m-labeled red blood cell scan (TRBC)Technetium 99m-labeled red blood cell scan (TRBC) Most commonly used methodMost commonly used method Long half life allows for repeat scanning in 24 hoursLong half life allows for repeat scanning in 24 hours Late pooled blood may not identify bleeding siteLate pooled blood may not identify bleeding site

Requires bleeding rate of 0.1 to 0.4 mL/minRequires bleeding rate of 0.1 to 0.4 mL/min

Positive in 45% all LGI bleedingPositive in 45% all LGI bleeding  Angiography verification highest (67%) when bleeding scan is Angiography verification highest (67%) when bleeding scan is

immediately positiveimmediately positiveData in obscure bleeding limitedData in obscure bleeding limited 15% false positive, 12-23% false negative15% false positive, 12-23% false negative Need verification by angiography or endoscopyNeed verification by angiography or endoscopy

Page 20: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 20/61

Obscure GI BleedingObscure GI Bleeding Angiography Angiography

Severe bleedingSevere bleeding

Bleeding rate of 0.5 mL/minBleeding rate of 0.5 mL/min

Positive in 27-77% of acute LGI bleedingPositive in 27-77% of acute LGI bleeding

Positive in 61-72% if,Positive in 61-72% if, Pt actively bleeding requiring transfusionPt actively bleeding requiring transfusion Hemodynamic compromiseHemodynamic compromise TRBC scan shows an immediate blushTRBC scan shows an immediate blush

 Administer anticoagulants, vasodilators, clot- Administer anticoagulants, vasodilators, clot-lysing agents to precipitate bleedinglysing agents to precipitate bleeding Increased diagnostic yield from 32 to 65%Increased diagnostic yield from 32 to 65% 17% complication rate including excessive bleeding17% complication rate including excessive bleeding

Page 21: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 21/61

Obscure BleedingObscure BleedingEnteroscopyEnteroscopy

Pass scope beyond the ligament of TreitzPass scope beyond the ligament of Treitz  Adult or pediatric colonoscope, SB Adult or pediatric colonoscope, SB

enteroscopeenteroscope

Diagnostic yield : 40-50%Diagnostic yield : 40-50%

 Angiodysplasia in 80% Angiodysplasia in 80%

 Advantage over capsule endoscopy Advantage over capsule endoscopy Sample tissueSample tissue

Endoscopic therapyEndoscopic therapy

Page 22: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 22/61

Obscure BleedingObscure BleedingIntraoperative EnteroscopyIntraoperative Enteroscopy

Transfusion dependentTransfusion dependent

Severe blood lossSevere blood loss

Risk of continued bleeding outweigh the risk of Risk of continued bleeding outweigh the risk of laparotomylaparotomy

Identifies bleeding source in 70 – 100%Identifies bleeding source in 70 – 100%

Technically difficultTechnically difficult  Adhesions, luminal blood, infiltrating neoplasia Adhesions, luminal blood, infiltrating neoplasia

Complications (procedure and post op)Complications (procedure and post op) Perforation, mucosal tears, mesenteric hemorrhage, prolongedPerforation, mucosal tears, mesenteric hemorrhage, prolonged

ileus, ischemia, wound infection, pneumoniaileus, ischemia, wound infection, pneumonia Mortality 11%Mortality 11%

Page 23: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 23/61

Obscure GI BleedingObscure GI BleedingIntraoperative EnteroscopyIntraoperative Enteroscopy

Page 24: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 24/61

Obscure GI BleedingObscure GI BleedingExploratory LaparotomyExploratory Laparotomy

Seldom without intraoperative enteroscopySeldom without intraoperative enteroscopy65% of 37 pt’s had lesion identified by65% of 37 pt’s had lesion identified by

palpation or transilluminationpalpation or transillumination

Page 25: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 25/61

1. The PillCam™ Capsule

2. SensorArray™ SB

3. Given® DataRecorder™

PillCam™ SB Exam SetPillCam™ SB Exam Set

2

1

3

Page 26: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 26/61

Wireless Capsule EndoscopyWireless Capsule EndoscopyPatient ExperiencePatient Experience

Sensors placed andSensors placed andattached to dataattached to datarecorder recorder 

Easily ingested,Easily ingested,painless procedurepainless procedure

Progresses naturallyProgresses naturallythrough the GI tractthrough the GI tract

via peristalsisvia peristalsisTransmits images toTransmits images todata recorder data recorder 

Page 27: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 27/61

PillCam™ SBPillCam™ SB Patient ExperiencePatient Experience

Liquid diet from lunch the day beforeLiquid diet from lunch the day before

Movie Prep the night beforeMovie Prep the night before

12 hour fast the night before12 hour fast the night beforeCapsule ingested in the morningCapsule ingested in the morning

Reglan or erythromycin for inpatientsReglan or erythromycin for inpatients

Liquid diet after 2 hoursLiquid diet after 2 hoursLight meal 4 hours after ingestionLight meal 4 hours after ingestion

Disconnect after 8 hoursDisconnect after 8 hours

Ob GI Bl diOb GI Bl di

Page 28: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 28/61

Pennazio M, Santucci R, Rondonotti E, et al. Gastroenterology 2004; 126: 643-653

82.6 %82.6 %Negative predictiveNegative predictivevaluevalue

97.0 %97.0 %Positive predictivePositive predictive

valuevalue

95.0 %95.0 %

SpecificitySpecificity

88.9 %88.9 %SensitivitySensitivity

(Analysis of patients with verified final diagnosis, n = 56)

Obscure GI BleedingObscure GI BleedingPillCam™ SBPillCam™ SB

Page 29: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 29/61

Obscure GI BleedingObscure GI Bleeding

PillCamPillCamTMTM

SBSB

CE results led to treatments resolvingCE results led to treatments resolving

thethe bleeding in 86.9% of patientsbleeding in 86.9% of patients

undergoing the procedure while activelyundergoing the procedure while activelybleeding.bleeding.

(12 – 25 month follow up)(12 – 25 month follow up)

Pennazio M, Santucci R, Rondonotti E, et al. Gastroenterology 2004; 126: 643-653

Page 30: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 30/61

If done early in the course of the workup,If done early in the course of the workup,

PillCamPillCam™™ endoscopy could:endoscopy could:

Shorten considerably the time to diagnosisShorten considerably the time to diagnosisLead to definitive treatment in a relevantLead to definitive treatment in a relevant

proportion of patientsproportion of patients

Spare a number Spare a number of alternative investigations withof alternative investigations with

low diagnostic yieldlow diagnostic yield 

Obscure GI BleedingObscure GI Bleeding

 Pennazio et al. 2004 ConclusionPennazio et al. 2004 Conclusion

Pennazio M, Santucci R, Rondonotti E, et al. Gastroenterology 2004; 126: 643-653

Page 31: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 31/61

Obscure GI BleedingObscure GI BleedingPillCamPillCamTMTM SBSB

StudyStudy SensitivitySensitivity (%)(%)

Specificity (%)Specificity (%) PPVPPV (%)(%) NPV (%)NPV (%)

Pennazio etPennazio etal.al.

Gastro 2004Gastro 2004

88.988.9 9595 9797 82.682.6

Delvaux et al.Delvaux et al.Endoscopy Endoscopy 20042004 

94.494.4 100100

Botelberge etBotelberge et

al.al.ICCE 2005 ICCE 2005 

91.691.6 86.386.3 8888 90.490.4

Hartmann etHartmann etal.al.GIE 2005 GIE 2005 

9595 7575 9595 8686

Page 32: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 32/61

First line diagnostic exam for visualization of First line diagnostic exam for visualization of small bowel mucosa.small bowel mucosa.

Clinical data reviewed 32 independent studiesClinical data reviewed 32 independent studieswhich indicate CE diagnostic yield of 71% vs.which indicate CE diagnostic yield of 71% vs.

41% diagnostic yield for all other modalities41% diagnostic yield for all other modalities combinedcombined11

Established as gold standard for diagnosis of Established as gold standard for diagnosis of disease of small intestinedisease of small intestine22

Now cleared in the US for pediatric populationNow cleared in the US for pediatric population from 10-18 years oldfrom 10-18 years old

1. Internal data at Given Imaging Ltd. Reviewed by the FDA

2. Rex, et. Al; WIRELESS CAPSULE ENDOSCOPY DETECTS SMALL BOWEL ULCERS IN 

PATIENTS WITH NORMAL RESULTS FROM STATE OF THE ART ENTEROCLYSIS The

 American Journal of Gastroenterology, Vol. 98, No. 6 

PillCam™ SBPillCam™ SBIndicationsIndications

Page 33: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 33/61

In patients with known or suspected gastrointestinalIn patients with known or suspected gastrointestinal

obstruction, strictures, or fistulas based on theobstruction, strictures, or fistulas based on the

clinical picture or pre-procedure testing and profile.clinical picture or pre-procedure testing and profile.

In patients with cardiac pacemakers or other In patients with cardiac pacemakers or other 

implanted electromedical devicesimplanted electromedical devices11..

In patients with swallowing disorders.In patients with swallowing disorders.

1

Leighton JA,, et al, SAFETY OF CAPSULE ENDOSCOPY IN PATIENTS WITH PACEMAKERS,Gastrointest Endosc. 2004 Apr;59(4):567-9. Concludes that capsule endoscopy appears to be

safe in patients with cardiac pacemakers and does not appear to be associated with any 

significant adverse cardiac event. Pacemakers do not interfere with capsule imaging.

PillCam™ SBPillCam™ SBContraindicationsContraindications

Page 34: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 34/61

Small Bowel BleedingSmall Bowel Bleeding

 CausesCauses Visualized by PillCamVisualized by PillCamTMTM

Vascular LesionsVascular Lesions  Angioectasias Angioectasias

NeoplasmsNeoplasms

Inflammatory LesionsInflammatory Lesions

Ulcers, Crohn’s DiseaseUlcers, Crohn’s DiseaseOther Other  Diverticula, varicesDiverticula, varices

Page 35: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 35/61

PillCamPillCamTMTM SBSBNormal EsophagusNormal Esophagus

Page 36: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 36/61

PillCamPillCamTMTM SBSBNormal StomachNormal Stomach

Page 37: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 37/61

PillCamPillCamTMTM SBSBNormalNormal

Page 38: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 38/61

PillCamPillCamTMTM SBSBVascular LesionsVascular Lesions

Page 39: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 39/61

PillCamPillCamTMTM SBSBVascular LesionsVascular Lesions

Page 40: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 40/61

PillCam™ SBPillCam™ SBCrohn´s DiseaseCrohn´s Disease

Strictured ulcer 

 A deep fissure can be seen in the

histological examination

Typical granulomas can be seen in

the wall of the small intestine

Page 41: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 41/61

PillCamPillCamTMTM SBSB Celiac Image SpectrumCeliac Image Spectrum

Page 42: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 42/61

PillCam™ SBPillCam™ SBUlcersUlcers

Page 43: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 43/61

PillCam™ SBPillCam™ SBPolyps and MassesPolyps and Masses

Page 44: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 44/61

PillCam™ SBPillCam™ SBDiverticulaDiverticula

Page 45: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 45/61

Wireless Capsule EndoscopyWireless Capsule EndoscopySummarySummary

Time efficient, patient friendly, sensitiveTime efficient, patient friendly, sensitive

method to visualize the small bowelmethod to visualize the small bowel

DisadvantagesDisadvantages No therapeuticsNo therapeutics

Unable to control movementUnable to control movement

Unable to clear bubbles and debrisUnable to clear bubbles and debris

D bl B ll E tD bl B ll E t

Page 46: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 46/61

Double Balloon EnteroscopyDouble Balloon Enteroscopy

First described by Yamamoto in 2001First described by Yamamoto in 2001

 Allows the diagnosis and treatment of disease Allows the diagnosis and treatment of disease

along the entire length of the small bowelalong the entire length of the small bowel

Entire SB visualized in 86% of patients (Yamamoto)Entire SB visualized in 86% of patients (Yamamoto)

Fujinon enteroscope overtube systemFujinon enteroscope overtube system 230 cm total length230 cm total length

200-cm working length200-cm working length

140-cm overtube140-cm overtube

2.8 mm channel for biopsy and therapeutic intervention2.8 mm channel for biopsy and therapeutic intervention

D bl B ll E

Page 47: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 47/61

Double Balloon EnteroscopyDouble Balloon Enteroscopy

 Also called “push-pull enteroscopy” Also called “push-pull enteroscopy”

 Advanced antegrade or retrograde Advanced antegrade or retrograde

Patient PrepPatient Prep  Antegrade: NPO 6-8 hrs Antegrade: NPO 6-8 hrs

Retrograde: Colo prepRetrograde: Colo prep

Moderate sedation, propofol, or generalModerate sedation, propofol, or generalanesthesiaanesthesia

Page 48: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 48/61

Double Balloon EnteroscopyDouble Balloon EnteroscopyComplicationsComplications

2/178 procedures (1.1%) by Yamamoto2/178 procedures (1.1%) by Yamamoto Post procedure fever and abdominal painPost procedure fever and abdominal pain

PerforationPerforation

40/2362 procedures (1.7%) by Mensink40/2362 procedures (1.7%) by Mensink 13/1728 diagnostic procedures (0.8%)13/1728 diagnostic procedures (0.8%)

27/634 therapeutic procedures (4.3%)27/634 therapeutic procedures (4.3%)

12/364 post polypectomy bleeding (3.3%)12/364 post polypectomy bleeding (3.3%)

3/253 post APC perforation (1.2%)3/253 post APC perforation (1.2%)

2/70 post balloon dilations perforation (2.9%)2/70 post balloon dilations perforation (2.9%)

Page 49: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 49/61

Courtesy of Fujinon and Yamamoto H et al 

Page 50: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 50/61

Courtesy of Fujinon and Yamamoto H et al 

Page 51: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 51/61

Courtesy of Fujinon and Yamamoto H et al 

Page 52: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 52/61

Antegrade (oral) DBE Retrograde (anal) DBE

D bl B ll E tD bl B ll E t

Page 53: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 53/61

Double Balloon EnteroscopyDouble Balloon Enteroscopy

ContraindicationsContraindications

Non-cooperative patientNon-cooperative patient

Prior intestinal perforationPrior intestinal perforation AAA AAA

Excessive deformity of cervical spineExcessive deformity of cervical spine

Yi ld f S ll B l I iYi ld f S ll B l I i

Page 54: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 54/61

Yield of Small Bowel ImagingYield of Small Bowel Imaging

Modalities in Obscure GI BleedingModalities in Obscure GI Bleeding

Length of Length of InsertionInsertion

YieldYield

DBEDBE Up to 100%Up to 100% 61 – 85%61 – 85%

PEPE 50 – 150 cm50 – 150 cm 15 – 50%15 – 50%

WCEWCE 100% SB100% SB 45 – 75%45 – 75%

IOEIOE Up to 100%Up to 100% 55 – 100%55 – 100%

RadiologyRadiology 100%100% 5%5%

GIE 2005, 61:6:709-714

Ob GI Bl di

Page 55: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 55/61

Obscure GI BleedingObscure GI BleedingManagementManagement

ResuscitationResuscitation Iron supplementation, correct coagulopathy andIron supplementation, correct coagulopathy and

platelet abnormalities, intermittent blood transfusionsplatelet abnormalities, intermittent blood transfusions

Endoscopic treatmentEndoscopic treatment Angiography Angiography

PharmacotherapyPharmacotherapy Estrogen therapyEstrogen therapy

OctreotideOctreotide

SurgerySurgery

Ob GI Bl diOb GI Bl di

Page 56: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 56/61

Obscure GI BleedingObscure GI BleedingEvaluationEvaluation

Repeat EGD and Colonoscopy (~ 35% yield)

If negative

Capsule Endoscopy (~ 60–70% yield)

If negative

Repeat Capsule Endoscopy (~ 35% yield)

If negative

Double Balloon Enteroscopy (~ 40% yield)

If negative

Intraoperative Enteroscopy in selected cases

GIE 2004;60:5:711-713

Page 57: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 57/61

Th F tTh F t

Page 58: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 58/61

The FutureThe FutureRoboticsRobotics

Page 59: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 59/61

Page 60: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 60/61

The Magic PillThe Magic Pill

Ob GI Bl diOb GI Bl di

Page 61: ObscureGIBleeding

8/3/2019 ObscureGIBleeding

http://slidepdf.com/reader/full/obscuregibleeding 61/61

Obscure GI BleedingObscure GI BleedingEvaluationEvaluation

Repeat EGD and Colonoscopy (~ 35% yield)

If negative

Capsule Endoscopy

If negative

Repeat Capsule Endoscopy

If negative

Double Balloon Enteroscopy

If negative

Intraoperative Enteroscopy in selected cases

GIE 2004;60:5:711 713